PT Jayamas Medica Industri Tbk (IDX:OMED)
228.00
0.00 (0.00%)
Aug 12, 2026, 11:49 AM WIB
IDX:OMED Revenue
PT Jayamas Medica Industri Tbk had revenue of 594.55B IDR in the quarter ending June 30, 2026, with 21.45% growth. This brings the company's revenue in the last twelve months to 2.30T, up 19.29% year-over-year. In the year 2025, PT Jayamas Medica Industri Tbk had annual revenue of 2.06T with 9.44% growth.
Revenue (ttm)
2.30T
Revenue Growth
+19.29%
P/S Ratio
2.67
Revenue / Employee
1.72B
Employees
1,340
Market Cap
6.16T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.06T | 177.99B | 9.44% |
| Dec 31, 2024 | 1.89T | 148.83B | 8.57% |
| Dec 31, 2023 | 1.74T | -2.06B | -0.12% |
| Dec 31, 2022 | 1.74T | -487.52B | -21.90% |
| Dec 31, 2021 | 2.23T | 232.03B | 11.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 37.72T |
| PT Enseval Putera Megatrading Tbk. | 35.18T |
| PT Siloam International Hospitals Tbk | 13.51T |
| PT Lippo Karawaci Tbk | 8.35T |
| PT Mitra Keluarga Karyasehat Tbk | 5.57T |
| PT Famon Awal Bros Sedaya Tbk | 2.77T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.70T |
| PT Sarana Meditama Metropolitan Tbk | 1.98T |